Company research

Cryo-Cell International Inc. (CCEL) stock fundamentals

Cryo-Cell International, Inc. engages in cellular processing and cryogenic cellular storage with a focus on the collection and preservation of umbilical cord blood stem cells for family use. It provides cord tissue servi

As of 2026-10-09

Exchange
XASE
Sector
Healthcare
Industry
Medical Care Facilities

Company overview

Cryo-Cell International, Inc. engages in cellular processing and cryogenic cellular storage with a focus on the collection and preservation of umbilical cord blood stem cells for family use. It provides cord tissue service that stores a section of the umbilical cord tissue, a source of mesenchymal stem cells, which are used in regenerative medicine to treat a range of conditions. The company manufactures and sells PrepaCyte CB processing system, a technology used to process umbilical cord blood stem cells. It markets its cord blood stem cell preservation services directly to expectant parents, as well as by distributing information through obstetricians, pediatricians, childbirth educators, certified nurse-midwives, and other related healthcare professionals. The company was incorporated in 1989 and is headquartered in Oldsmar, Florida.

Daily valuation snapshot

These values come from the daily market snapshot dated 2026-10-09. TTM means trailing twelve months. Use the market date when comparing CCEL with another company.

Daily close (USD)$4.36
Market capitalization (USD)$35,153,154
Price / earnings (TTM)Not reported
Price / bookNot reported

Read CCEL's valuation metrics

  1. Company size

    Cryo-Cell International Inc.'s recorded market capitalization is $35,153,154. It measures the market value of the company's equity, rather than its revenue or cash balance.

  2. Price relative to earnings

    P/E compares share price with trailing annual earnings per share. For a company with losses, inspect the earnings figures directly rather than treating a negative multiple as a cheap valuation.

  3. Price relative to book equity

    Price-to-book compares market equity value with recorded book equity. Intangible assets, profitability and the company's business affect how useful the comparison is.

Research Cryo-Cell International Inc. with Aurora

Use the snapshot above to ask a specific question about CCEL. Ask for the report period and the figures behind the explanation, then compare the answer with the company's business description.

Continue the research

Follow CCEL's ownership disclosures to see who filed a transaction or position and when it became public. To turn a research idea into a strategy, define an entry rule and test its dated observations.

Aurora · AI research assistant

Try this in Aurora

Edit the request, then open it in Aurora. You choose when to send it.